A Phase II Study of CP-4126 in Patients With Advanced Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2014
At a glance
- Drugs Gemcitabine elaidate (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Aqualis
- 07 Jun 2017 Biomarkers information updated
- 05 Oct 2012 Planned number of patients changed from 40 to 120 as reported by European Clinical Trials Database.
- 09 Feb 2012 Actual patient number (21) added as reported by ClinicalTrials.gov.